Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histocytosis and Erdheim-Chester disease

dc.contributor.author	Váradi, Zsófia
dc.contributor.author	Bánusz, Rita
dc.contributor.author	Csomor, Judit
dc.contributor.author	Krisztián Kállay
dc.contributor.author	Varga, Edit
dc.contributor.author	Kertész, Gabriella
dc.contributor.author	Csóka, Monika
dc.date.accessioned	2017-06-12T07:00:29Z
dc.date.available	2017-06-12T07:00:29Z
dc.date.issued	2017
dc.identifier.citation	pagination=521-526; journalVolume=10; journalTitle=ONCOTARGETS AND THERAPY;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/4206
dc.identifier.uri	doi:10.2147/OTT.S121615
dc.relation.ispartof	urn:issn:1178-6930
dc.title	Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histocytosis and Erdheim-Chester disease
dc.type	Journal Article
dc.date.updated	2017-03-31T10:26:03Z
dc.language.rfc3066	en
dc.identifier.mtmt	3171310
dc.identifier.pubmed	28182116
dc.contributor.department	SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika
dc.contributor.department	SE/AOK/I/I. Sz. Patológiai és Kísérleti Rákkutató Intézet
dc.contributor.institution	Semmelweis Egyetem